These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 16907893)
1. Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea. Yearsley KA; Gilby LJ; Ramadas AV; Kubiak EM; Fone DL; Allison MC Aliment Pharmacol Ther; 2006 Aug; 24(4):613-9. PubMed ID: 16907893 [TBL] [Abstract][Full Text] [Related]
2. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients. Aseeri M; Schroeder T; Kramer J; Zackula R Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653 [TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection. Turco R; Martinelli M; Miele E; Roscetto E; Del Pezzo M; Greco L; Staiano A Aliment Pharmacol Ther; 2010 Apr; 31(7):754-9. PubMed ID: 20047577 [TBL] [Abstract][Full Text] [Related]
4. Clostridium difficile-associated diarrhoea in patients with human immunodeficiency virus infection: a case-control study. Tumbarello M; Tacconelli E; Leone F; Cauda R; Ortona L Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):259-63. PubMed ID: 7743309 [TBL] [Abstract][Full Text] [Related]
5. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Howell MD; Novack V; Grgurich P; Soulliard D; Novack L; Pencina M; Talmor D Arch Intern Med; 2010 May; 170(9):784-90. PubMed ID: 20458086 [TBL] [Abstract][Full Text] [Related]
6. Mortality of patients with antibiotic-associated diarrhoea: the impact of Clostridium difficile. Bishara J; Peled N; Pitlik S; Samra Z J Hosp Infect; 2008 Apr; 68(4):308-14. PubMed ID: 18353491 [TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors and hospitalization for Clostridium difficile-associated disease: a population-based study. Lowe DO; Mamdani MM; Kopp A; Low DE; Juurlink DN Clin Infect Dis; 2006 Nov; 43(10):1272-6. PubMed ID: 17051491 [TBL] [Abstract][Full Text] [Related]
9. Failure of dietary oligofructose to prevent antibiotic-associated diarrhoea. Lewis S; Burmeister S; Cohen S; Brazier J; Awasthi A Aliment Pharmacol Ther; 2005 Feb; 21(4):469-77. PubMed ID: 15709999 [TBL] [Abstract][Full Text] [Related]
10. Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy. King RN; Lager SL Pharmacotherapy; 2011 Jul; 31(7):642-8. PubMed ID: 21923450 [TBL] [Abstract][Full Text] [Related]
11. Specific risk factors for Clostridium difficile-associated diarrhea: a prospective, multicenter, case control evaluation. Vesta KS; Wells PG; Gentry CA; Stipek WJ Am J Infect Control; 2005 Oct; 33(8):469-72. PubMed ID: 16216661 [TBL] [Abstract][Full Text] [Related]
12. Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors. Debast SB; Vaessen N; Choudry A; Wiegers-Ligtvoet EA; van den Berg RJ; Kuijper EJ Clin Microbiol Infect; 2009 May; 15(5):427-34. PubMed ID: 19416295 [TBL] [Abstract][Full Text] [Related]
13. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Pépin J; Saheb N; Coulombe MA; Alary ME; Corriveau MP; Authier S; Leblanc M; Rivard G; Bettez M; Primeau V; Nguyen M; Jacob CE; Lanthier L Clin Infect Dis; 2005 Nov; 41(9):1254-60. PubMed ID: 16206099 [TBL] [Abstract][Full Text] [Related]
15. Clostridium difficile infection in an urban medical center: five-year analysis of infection rates among adult admissions and association with the use of proton pump inhibitors. Jayatilaka S; Shakov R; Eddi R; Bakaj G; Baddoura WJ; DeBari VA Ann Clin Lab Sci; 2007; 37(3):241-7. PubMed ID: 17709687 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease. Dubberke ER; Reske KA; Olsen MA; McMullen KM; Mayfield JL; McDonald LC; Fraser VJ Arch Intern Med; 2007 May; 167(10):1092-7. PubMed ID: 17533213 [TBL] [Abstract][Full Text] [Related]
17. [The frequency of Clostridium difficile toxin in neutropenic and non-neutropenic patients with antibiotic-associated diarrhea and analysis of the risk factors]. Tunçcan OG; Ulutan F; Karakuş R Mikrobiyol Bul; 2008 Oct; 42(4):573-83. PubMed ID: 19149078 [TBL] [Abstract][Full Text] [Related]
18. Fatal chemotherapy associated Clostridium difficile infection--a case report. Wong AS; Lam CS; Tambyah PA Singapore Med J; 2001 May; 42(5):214-6. PubMed ID: 11513059 [TBL] [Abstract][Full Text] [Related]
19. Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factors. Sundram F; Guyot A; Carboo I; Green S; Lilaonitkul M; Scourfield A J Hosp Infect; 2009 Jun; 72(2):111-8. PubMed ID: 19386381 [TBL] [Abstract][Full Text] [Related]
20. Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system. McFarland LV; Clarridge JE; Beneda HW; Raugi GJ Clin Infect Dis; 2007 Nov; 45(9):1141-51. PubMed ID: 17918075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]